ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spitzer, E.
Right arrow Articles by Grosse, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spitzer, E.
Right arrow Articles by Grosse, R.
Eur Respir J 2002; 19:374-376
Copyright ©ERS Journals Ltd 2002

Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient

E. Spitzer1, D. Staab2, R. Hanke1, U. Wahn2 and R. Grosse1

1 Institute of Medical Molecular Diagnostics Ltd, Berlin, and 2 Christiane Herzog Centre, Chest Clinic Heckeshorn, Berlin, Germany

CORRESPONDENCE: E. Spitzer, Institute of Medical Molecular Diagnostics, Schoenstrasse 90, 13086, Berlin, Germany. Fax: 49 309209071. E-mail: labor@immdonline.com

Keywords: cystic fibrosis, cystic fibrosis transmembrane regulator gene mutation, oligo­ligation assay

Received: July 2, 2001
Accepted July 31, 2001

By using a combination of multiplex polymerase chain reaction and allele­specific labelled probes, the oligo­ligation assay is designed to detect known cystic fibrosis transmembrane regulator mutations. This study shows that this assay may also be useful to detect new mutations.

The second child of a family of Bosnic origin showed all the symptoms of intestinal and pulmonary manifestations of cystic fibrosis. No signal could be obtained for the allele­specific probe 1898+1G>A. This could be explained by a nearby localized sequence change that prevented polymerase chain reaction primers or oligonucleotide probes from binding to the target sequence. Indeed, sequence analysis revealed a new 1894G>T exchange (Glu587Stop). Both parents and the healthy brother carried this mutation. Thus, the index patient was homozygous for 1894G>T, which was inherited from both parents.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.